Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05660954
Title Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer. (CABOTHYROID)
Acronym CABOTHYROID
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Espanol de Tumores Neuroendocrinos
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Universitario Central de Asturias Oviedo Asturias 33011 Spain Details
Hospital Universitario Rey Juan Carlos Móstoles Madrid 28933 Spain Details
Complexo Hospitalario Universitario A Coruña A Coruña 15006 Spain Details
Hospital Universitario Vall d'Hebron Barcelona 08035 Spain Details
Hospital Clínic de Barcelona Barcelona 08036 Spain Details
Hospital Universitario Ramón y Cajal Madrid 28034 Spain Details
Hospital Clínico San Carlos Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital General Universitario Morales Meseguer Murcia 30008 Spain Details
Complejo Asistencial Universitario de Salamanca Salamanca 37007 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field